Axicabtagene Ciloleucel versus Tisagenlecleucel for Relapsed or Refractory Large B Cell Lymphoma: A Systematic Review and Meta-Analysis

Gagelmann, Nico; Bishop, Michael; Ayuk, Francis; Bethge, Wolfgang; Glass, Bertram; Sureda, Anna; Pasquini, Marcelo C.; Kroeger, Nicolaus

dc.contributor.author	Bethge, Wolfgang Andreas
dc.date.accessioned	2025-01-14T07:39:45Z
dc.date.available	2025-01-14T07:39:45Z
dc.date.issued	2024
dc.identifier.issn	2666-6375
dc.identifier.uri	http://hdl.handle.net/10900/160079
dc.language.iso	en	de_DE
dc.publisher	New York : Elsevier Science Inc	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.jtct.2024.01.074	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Axicabtagene Ciloleucel versus Tisagenlecleucel for Relapsed or Refractory Large B Cell Lymphoma: A Systematic Review and Meta-Analysis	de_DE
dc.type	Article	de_DE
utue.quellen.id	20241001000000_01401
utue.publikation.seiten	584.e1-584.e13	de_DE
utue.personen.roh	Gagelmann, Nico
utue.personen.roh	Bishop, Michael
utue.personen.roh	Ayuk, Francis
utue.personen.roh	Bethge, Wolfgang
utue.personen.roh	Glass, Bertram
utue.personen.roh	Sureda, Anna
utue.personen.roh	Pasquini, Marcelo C.
utue.personen.roh	Kroeger, Nicolaus
dcterms.isPartOf.ZSTitelID	Transplantation and Cellular Therapy	de_DE
dcterms.isPartOf.ZS-Issue	6	de_DE
dcterms.isPartOf.ZS-Volume	30	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE